Member Info for btbt

Only on the London markets could a company be valued at 1/3rd of yearly profit.

London markets are a laughing stock, no wonder everyone is leaving for New York. I will hold on to this because surely the market will wake up one day however London and particularly AIM is a joke.

These numbers are completely mind blowing. £63m revenue in 2023 resulted in £61m of EBITDA, I've never seen a margin anywhere near that level in my life.

The disconnect between market cap and financial performance is absolutely huge. This could go up 4-fold from here and still be incredibly undervalued with a P/E ratio of 1. Something surely has to give

There is a lot more info re CSS in the BARK RNS's. The ROAD RNS this week made it sound like CSS is dealing in peanuts amounts, however a recent RNS under BARK says the following which paints it in a completely different light, and makes the partial sale this week make more sense:

'CSS has achieved significant success licensing its ground-breaking technologies during the year, securing agreements with Sleep Sense International Limited and Massimo Consumer Audio. CSS expects to generate revenues in excess of £10 million over the next three years, based on the licence deals already signed and announced and anticipates generating revenues from these in Q4 2023.

CSS is also in advanced negotiations with several household names on a number of new multi-year enterprise licensing deals for its SleepEngine® technology. Further announcements will be made as soon as practicable when these licences are signed. These agreements are expected to deliver significant additional revenues to the business over the coming years.

Given the commercial opportunity SleepEngine® presents, the Board has appointed advisers to undertake a strategic review of Barkby's investment in Cambridge Sleep Sciences as the Company focuses on its Roadside Real Estate strategy.

There can be no certainty that any offer or sale will ultimately be made for CSS or the value of any such proposed deal.'

this will not move for months. 166m shares need to be dumped by the funder and on top of that extremely annoyed holders are dumping their shares - me included.

this absolutely stinks. never invest in a company where the bod doesn't give a **** about shareholders. completely fed up of being screwed by financially illiterate ceos and information being leaked before us peasants get notified. how were there no funding plans in place for this? fuming

out with a significant loss. **** this company and the bod. insulting placing with insider info to boot. hope the fca steps in

The next catalyst here will be the funding confirmation. IMO with each day that passes a placing becomes less likely and funding via a party such as Prevail is more likely. Prevail will fund this at a minimum if the previous rate of 6p, if not more.

Small top up from me today too, this seems like as cheap as it will get.

Perfect storm of heavily undervalued, heavily shorted, and new due. 6p+ within a week of two.

If this was listed in the US the share price would be 5 times higher. Rapidly growing pharma company using AI in their product development, they would love it.

London markets are a joke where the only people that make money are MMs and shorters. Compare the FTSE to the S&P, tells you all you need to know.

They should have played up the good news. Pushed the SP higher then done an ordinary discounted raise at 15/20p; consolidating the SP and building a platform to move higher.

Instead they basically couldn't be bothered, pressed the reset button on all the progress and send us back to 5p - happy in the knowledge that they've plundered enough money to keep the lights on and pay their salaries for another year. It is maddening.

This is a shambles. The board couldn't give a toss about shareholders.

Basically none of the positive developments were mentioned in the update and we get lumped with a placing with no floor price in an illiquid market. Complete joke. 70% down from peak in a week and still crashing, a job very well done.

There is nothing sensible about doing a fund raise with no floor price. The board should be savvy enough to know how the markets work and know that this will destroy the share price.

Secondly, if it does turn out to be a case of mates rates then that is absolutely criminal. The board are there to look after the shareholders, not their own pockets or their mates.

Either way you look at it, this is extremely poor from the board. Shareholder value is clearly not their first priority.

Precisely re the funding part. Very worrying that countless punters on a message board could see this coming months ago but not out CEO.

I also question what the point of the court battle is. We borrowed $3m, we approached them to repay it, they asked for $3m back - So we take them to court? What? They are surprised that the loan shark want their money back? Why drag this on for another 6 months? just repay it because that will be the end result anyway. Incredibly frustrated by this BOD.

The CLN's have been a complete disaster for TNT and continue to completely kill this stock. There was such a buzz around this in the second half of 2022 and now it couldn't be more flat. 0 messages posted and 5 trades a day is a million miles from where it was in Q3-Q4 2022.

I am very concerned that the directors couldn't foresee that this would happen and worry that they won't be able to dig themselves out of the hole they created for themselves. I fear that too much damage has been done to sentiment and they will struggle to get funding anywhere near the levels seen in the past.

What happened to the monthly Q&A's promised? Where are the progress reports? All we've heard in months is that an FCA application was withdrawn and resubmitted. Is that all there is to say?

Useless naive board. who could have foreseen a shady AIM death spiral finance company wouldn't act in good faith?

This entire BB saw it coming but the board didn't. Absolutely useless

The CLN's are hampering Tintra as our SP is stuck at the conversion floor price (and pretty much always will be whilst they exist, regardless of news). It therefore makes additional funding much more difficult as they are trying to raise at £11 per share when we are sat at £1 per share on the market. If we were up at say £4 or £5 then it makes it far easier.

$2m should be received today and I'm hoping there will be updates regarding further funding. The last RNS stated:

'Once the US$2.0m from the Subscription announced today is received as per the above timetable, US$12m (out of the Board's target to raise circa US$25m) will have been raised under the current funding round.'

'We continue to make headway in the funding round, both with conversations that have been ongoing for some time and with new conversations starting. We have strategically now broadened the geographic footprint of our funding discussions in line with both macro-economic realities and the advancing nature of the Puerto Rico IFE application. As such we are now for the first time in funding discussions in Latin America over the past few weeks from where we hope the next amounts to come from.'

I don't think Tintra would say that they've achieved 12m out of a 25m target unless they were comfortable that they'd get the rest. It looks like a failure otherwise so I don't think they would have bought attention to it. I'm hoping for an update on the Latin investors that they've been speaking to.

Regarding the CLN's - It appears that the 4 month window to drawdown more funds has expired. This is good as it means there should be no more, but it would be good to have conformation from Tintra on this. Best case scenario: 'We've received the $2m and have used it to pay off the remaining CLNs' - We can hope...

Yep they are going to try and raise the entire market cap in exchange for about 6% of the shares - Good luck with that.

All but written my investment off here, how have they messed this up so bad given the premium raises. Amateur.

It's beyond frustrating trying to imagine where we would be with out these f%cking CLNs.

Over the past few weeks we've announced funding at £11, £100k of director buys, and are now rubbing shoulders with trillion dollar companies it Washington yet our SP has still gone down.

Will the penny ever drop for RS that these CLNs are a complete disaster and make Tintra uninvestable

Market cap of £16m means that if the CLN holders exercised their £3m now, they would own over 20% of the company after discounts.

A huge kick in the teeth for the HNW investors who paid £10m for 6%. The CEO has a lot to answer for.

Spot on. CLN's are a disaster. I think we would be trading above £5 if these things didn't exist, which would make everything far easier.

Instead our CEO is happy to depress the SP, put essentially all investors under water, and make his own life infinitely harder when looking for further funding at a 1000% premium rather than 100%.

All for the sake of 2 or 3 million quid. Incredibly naïve decision and he has since doubled down saying that diversification is good?? It's the equivalent of taking a 85% APR payday loan to renovate your kitchen rather than remortgaging for the sake of diversifying.